Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanying Tang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neoplasia (New York, N.Y.)|December 31, 2016
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of ApoptosisYongxing Gong, Steven E Schumacher, Wei H Wu, et al.
Cancer Discovery|June 18, 2020
Lineage Reversion Drives WNT Independence in Intestinal CancerTeng Han, Sukanya Goswami, Yang Hu, et al.
Cancer Research Communications|June 9, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World DataLang Ho Lee, Xin Xu, Thanos Mourikis, et al.
Nature Cell Biology|December 28, 2021
Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptabilityPeipei Guo, Ying Liu, Fuqiang Geng, et al.
Science Advances|April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancerDan Li, Yu Zhan, Naitao Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Multi-ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic DermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
Nature Communications|March 31, 2025
Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
The Journal of Clinical Investigation|July 19, 2022
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic virusesJuan Yan, Yuedan Chen, Amish J Patel, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neoplasia (New York, N.Y.)|December 31, 2016
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of ApoptosisYongxing Gong, Steven E Schumacher, Wei H Wu, et al.
Cancer Discovery|June 18, 2020
Lineage Reversion Drives WNT Independence in Intestinal CancerTeng Han, Sukanya Goswami, Yang Hu, et al.
Cancer Research Communications|June 9, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World DataLang Ho Lee, Xin Xu, Thanos Mourikis, et al.
Nature Cell Biology|December 28, 2021
Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptabilityPeipei Guo, Ying Liu, Fuqiang Geng, et al.
Science Advances|April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancerDan Li, Yu Zhan, Naitao Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Multi-ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic DermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
Nature Communications|March 31, 2025
Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
The Journal of Clinical Investigation|July 19, 2022
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic virusesJuan Yan, Yuedan Chen, Amish J Patel, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Pageof 1